Filing Details
- Accession Number:
- 0000059478-15-000064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-03 16:06:43
- Reporting Period:
- 2015-02-01
- Filing Date:
- 2015-02-03
- Accepted Time:
- 2015-02-03 16:06:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1359067 | W Derica Rice | Lilly Corporate Center Indianapolis IN 46285 | Evp-Global Services And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-01 | 26,581 | $0.00 | 82,739 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-01 | 12,294 | $72.00 | 70,445 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2015-02-02 | 10,068 | $71.84 | 60,377 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2015-02-01 | 26,581 | $0.00 | 26,581 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-02-01 | 2015-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,958 | Indirect | 401(k) |
| Common Stock | 278,263 | Indirect | by wife |
| Common Stock | 1,809 | Indirect | 401(k) - by wife |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2014.
- This transaction was executed in multiple trades at prices ranging from $71.64 to $71.96. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Reporting person disclaims beneficial ownership of these shares.
- Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Billionaire Hedge Funds
